ArticleBone & joint open2025
The future of precision orthopaedics: personalized data-driven practice.
Article in Bone & joint open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Precision medicine in orthopaedics: A review of current technologies and future directions.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Review
- Artificial intelligence in orthopedic regenerative medicine: from design to clinical translational pathways.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in orthopaedic surgery have been significantly shaped by evidence-based medicine (EBM), which relies on randomized controlled trials (RCTs) to standardize care and improve outcomes. However, EBM's one-size-fits-all approach often fails to account for the heterogeneous nature of individual patients, limiting its ability to deliver personalized care. Personalized data-driven practice (PDDP), powered by AI, provides a transformative solution by integrating diverse data sources, including genetic and clinical data, imaging, and wearable device outputs, into patient-specific treatment strategies. This paper examines the complementary roles of EBM and PDDP, highlighting the capacity of AI-driven tools to enhance decision-making in orthopaedics. AI technologies, such as machine learning and Bayesian networks, enable predictive analytics, treatment personalization, and real-time data integration, fostering a shift from reactive to proactive care. However, challenges related to data quality, algorithm transparency, ethical considerations, and infrastructure development must be addressed to ensure robust and equitable implementation. By merging AI-enhanced PDDP with the established principles of EBM, orthopaedic practice can evolve into a hybrid model that enhances patient outcomes while preserving clinician oversight and ethical integrity. This integration heralds a new era of precision orthopaedics, offering a patient-centred approach in the context of big data and AI innovation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.